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ABSTRACT 
Aim: The overall aim of this thesis was to improve our knowledge of breast 
hypertrophy in women, its associated problems, and the outcome of breast 
reduction. 
Patients and methods: I. Five hundred and twelve woman were studied 
retrospectively for prevalence of and risk factors for complications. II. The 
study included 325 women, either randomized to prophylactic antibiotics or 
not. III. The Breast Evaluation Questionnaire (BEQ) for women with breast 
hypertrophy and breast reduction was validated. Two hundred and twenty-
five women who had had breast reduction surgery and 216 controls were 
included. IV. Three hundred and forty-eight women were evaluated for gain 
in health-related quality of life (HRQL) after breast reduction surgery in this 
prospective, longitudinal paired study.Results: I. A long suprasternal notch 
to nipple distance increased the risk of infection and necrosis of the nipple. 
High BMI increased the risk of wound infection. A larger weight of resection 
increased the risk of delayed wound healing and fat necrosis. Smokers have 
twice the risk of getting a postoperative infection and diabetics are at higher 
risk of nipple necrosis. II. The incidence of postoperative infections was not 
significantly different between the groups. III. The modified BEQ is valid 
and shows good reliability. IV. Breast hypertrophy is associated with low 
HRQL, and breast reduction surgery increases HRQL. Conclusions: I. Ster-
nal notch to nipple distance, BMI, resection weight, diabetes mellitus, and 
smoking are independent risk factors for complications after breast reduction 
surgery. II. One prophylactic dose of 2 g intravenous Cloxacillin or 600 mg 
Clindamycin did not reduce the incidence of postoperative infections. III. 
The BEQ has proven to be valid and to have good stability after being modi-
fied (mBEQ), when used before and after breast reduction surgery. IV. 
Women with breast hypertrophy have reduced quality of life and the HRQL 
is strongly increased or normalized after breast reduction surgery when SF-
36, mBEQ, BRSQ, and BREAST-Q are analyzed. Those with a higher body 
mass index, a longer sternal notch to nipple distance, a larger preoperative 
breast volume, or large volume of breast resection enjoy gains in health-
related quality of life that are similar to, although probably not greater than, 
other women.  
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